You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The Efficacy of Topical Ciprofloxacin and Norfloxacin in the Treatment of Experimental Pseudomonas Keratitis.

Reidy, James J. M.D.; Hobden, Jeffery A. M.S.; Hill, James M. Ph.D.; Forman, Kim; O'Callaghan, Richard J. Ph.D.

: An aminoglycoside-resistant strain of Pseudomonas aeruginosa was injected intrastromally into the corneas of rabbits, and keratitis was allowed to develop over a 22-h period. Rabbits were treated with either 0.75% ciprofloxacin, 1% norfloxacin, or 1.36% tobramycin administered topically every 15 min for 1 h and then every 30 min for the following 3 h. All therapy ceased 26 h postinoculation. Rabbits were killed 1 h after the treatment, and the number of bacteria per cornea were quantified in terms of bacterial colony-forming units. Aqueous humor specimens were obtained from rabbits receiving norfloxacin and ciprofloxacin, and bioassays were performed to determine drug concentration. Ciprofloxacin caused a 5 log reduction in the number of bacterial colony-forming units, as compared with untreated controls (p < 0.0001); it also produced a significantly greater reduction in bacterial colony-forming units than either norfloxacin or fortified tobramycin drops (p < 0.0001). Norfloxacin produced a 2 log reduction in bacterial colony-forming units, as compared with untreated controls (p < 0.0001). The mean aqueous concentration of norfloxacin (7.5 [mu]g/ml) was substantially less than that achieved by ciprofloxacin (30.5 [mu]g/ml). We conclude that ciprofloxacin may be a useful broad spectrum, topical chemotherapeutic agent in the therapy of aminoglycoside-resistant P. aeruginosa keratitis.

(C) Lippincott-Raven Publishers.